The global pharmaceutical caps and closure packaging market was valued at USD 16.15 billion in 2025 and is expected to reach USD 32.77 billion by 2030, growing at a CAGR of 15.0%. The increasing demand for secure, sustainable packaging solutions that protect pharmaceutical products from contamination and ensure compliance with stringent regulations is a key driver of this market growth. Innovations in child-resistant and tamper-evident packaging are significantly contributing to the pharmaceutical caps and closure packaging market. Additionally, the expanding pharmaceutical contract manufacturing sector and the growing demand for small and medium-sized closures are boosting the market for pharmaceutical caps and closures.
In 2023, Amcor plc entered a strategic partnership with Berry Global to enhance its healthcare packaging segment. The partnership strategy aims to strengthen Amcor’s capabilities in delivering innovative packaging solutions for pharmaceutical applications. This will expand its portfolio by improving product offerings and service delivery, further solidifying its position in the pharmaceutical caps and closure packaging market.
To know about the assumptions considered for the study download the pdf brochure
In 2023, Gerresheimer launched Gx Cap, a high-precision digital closure for enhanced patient compliance. This product launch allows Gerresheimer to market its advanced closure technology, which offers improved compliance in medication administration and monitoring, a capability the company has successfully introduced to meet evolving market demands.
The key players in this market are Amcor plc (Switzerland), Gerresheimer AG (Germany), AptarGroup (US), West Pharmaceutical Services (US), Silgan Holdings (US), Weener Plastics Group (Netherlands), Bericap (Germany), Closure Systems International (US), Bormioli Pharma (Italy), and Guala Closures (Italy), among others, who are expanding and enriching the market with their innovative equipment for workflow efficiency and healthcare quality.
Amcor plc, a leading company based in Switzerland, has captured significant market share in the pharmaceutical caps and closure packaging market due to its innovative and effective packaging solutions. As a prominent player in healthcare packaging and materials technology, Amcor offers pharmaceutical caps and closures that not only deliver secure containment but also provide effective protection for pharmaceutical products. Over the years, Amcor has continually improved and expanded its range of pharmaceutical packaging solutions, including child-resistant closures and tamper-evident designs, to ensure product safety and high levels of customer satisfaction. In 2022, Amcor plc secured a contract with a major pharmaceutical company for its innovative AmSky packaging, demonstrating its commitment to meeting stringent industry requirements.
Gerresheimer AG, based in Germany, secured one of the highest market shares in the pharmaceutical caps and closure packaging market. Gerresheimer specializes in pharmaceutical packaging solutions, and over time, it has become an important player in drug containment and delivery systems. The company is known for delivering excellent products with innovative features, such as precision engineering and digital integration, improving the quality of life for patients requiring pharmaceutical products. In recent years, Gerresheimer has expanded its capabilities through strategic acquisitions, including the acquisition of flexible packaging capabilities in 2022 to expand its product offerings, aiming to introduce advanced closure technologies and help pharmaceutical companies gain better control over medication administration and monitoring.
MARKET RANKING
The key players in the pharmaceutical caps and closure packaging market have gained recognition for their comprehensive product offerings and continuous technological innovations. Some of the major players in the pharmaceutical caps and closure packaging market include Amcor plc (Switzerland), Gerresheimer AG (Germany), AptarGroup (US), West Pharmaceutical Services (US), and Silgan Holdings (US). Amcor plc and Gerresheimer AG have gained recognition for offering sophisticated packaging solutions, including child-resistant and tamper-evident closures for pharmaceutical applications. Schott AG and AptarGroup maintain market leadership through their integrated pharmaceutical packaging systems, enabling secure containment, precise dosing, and prompt clinical decision-making in both routine and specialized pharmaceutical settings. Other notable contributors are expanding and enriching the market with their innovative equipment for workflow efficiency and healthcare quality. The key players have contributed significantly, increasing the reach of pharmaceutical caps and closure packaging solutions across global markets, with North America leading with a value of USD 4.7 billion in 2025 and a projected CAGR of 14.5% during the forecast period.
Related Reports:
Pharmaceutical Caps and Closure Packaging Market by Type (Screw Caps, Crimp-ons, Press-ons, Roll-ons, Frictions), Material (Plastic, Elastomer, Metal), Packaging Type (Child-resistant, Tamper-evident, End User, and Region - Global Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE